Functions of FGF21 and its role in cardiac hypertrophy

Lei Chen1, Meng Gao1, Sang-Bing Ong2

  • 1Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China; Institute for Regenerative Medicine, State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.

PubMed
Abstract

Insights

Fibroblast Growth Factor 21 (FGF21) shows promise in treating cardiac hypertrophy by regulating metabolism and stress pathways. Further research is needed to overcome limitations in clinical applications.

Area of Science:

  • Cardiovascular Biology
  • Endocrinology
  • Molecular Medicine

Background:

  • Fibroblast Growth Factor 21 (FGF21) is a hormone induced by stress.
  • FGF21 expression is elevated in cardiac hypertrophy, offering protection against heart injury.
  • Current preclinical and clinical applications of FGF21 for cardiac hypertrophy are limited.

Purpose of the Study:

  • To review the multifaceted roles of FGF21.
  • To explore the connection between FGF21 functions and cardiac hypertrophy.
  • To discuss challenges and future directions for FGF21-based therapies.

Main Methods:

  • Literature review of FGF21 functions.
  • Analysis of FGF21's regulatory mechanisms in cardiac hypertrophy.
  • Synthesis of current research on FGF21 and heart disease.

Main Results:

  • FGF21 influences energy metabolism, inflammation, oxidative stress, apoptosis, and autophagy.
  • FGF21 regulates cardiac hypertrophy initiation and progression via these pathways.
  • FGF21 demonstrates potential therapeutic benefits for cardiac hypertrophy.

Conclusions:

  • FGF21 plays a significant role in modulating key cellular processes relevant to cardiac hypertrophy.
  • Understanding FGF21's mechanisms offers insights into novel therapeutic strategies.
  • FGF21 represents a promising candidate for treating cardiac hypertrophy.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K